⌘K

Login Start Free

Home/Filings/4/0001209191-12-002135

4//SEC Filing

Reeth Mark D 4

Accession 0001209191-12-002135

CIK 0001009356other

View on SEC.gov Company Profile

Filed

Jan 4, 7:00 PM ET

Accepted

Jan 5, 4:34 PM ET

Size

4.8 KB

Accession

0001209191-12-002135

Insider Transaction Report

Form 4

Period: 2012-01-03

SALIX PHARMACEUTICALS LTDSLXP

Gen Counsel&VP Corp Compliance

Transactions

Tax Payment
Common Stock
2012-01-03$47.85/sh−923$44,166→ 34,668 total

Footnotes (1)

[F1]Represents shares forfeited to the company in connection with the satisfaction of tax liabilities incurred upon the vesting of restricted stock.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

SALIX PHARMACEUTICALS LTD

CIK 0001009356

Entity typeother

Related Parties

1

filerCIK 0001399353

Filing Metadata

Form type: 4
Filed: Jan 4, 7:00 PM ET
Accepted: Jan 5, 4:34 PM ET
Size: 4.8 KB

View on SEC.gov